Cancer Genetics Inc. appointed Michael McCartney as chief commercial officer, effective June 12.
McCartney will be responsible for developing and overseeing Cancer Genetics' commercial strategy and heading its business development initiatives. He previously served as CEO at SCIKON Innovation Inc.
Cancer Genetics develops, commercializes and provides molecular and biomarker-based tests and services in the U.S., India and China.
